Skip to content

Evaluation of the Performance of the Motus Cleansing System

Evaluation of the Performance of the Motus Cleansing System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02161536
Acronym
MSC
Enrollment
47
Registered
2014-06-11
Start date
2014-07-31
Completion date
2017-03-31
Last updated
2018-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy Procedure

Brief summary

The purpose of this study is evaluate the Motus GI Colon Cleansing system performance.

Detailed description

Subjects indicate for colonoscopy procedure undergo a limited bowel preparation including 20 mg Bisacodyl (4\*4 tables of 5 mg each) in split dose undergo standard colonoscopy with MCS. following the procedure 2 follow-up call were conducted at 48 hours and 14 days after to the procedure.

Interventions

Sponsors

Motus GI Medical Technologies Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Bowel cleansing level was evaluated by using the Boston Bowel Preparation Score (BBPS) at baseline and after the use of the Motus Cleansing System.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects in the age range of 18-75 years * Subjects with BMI within the range of 18.5-35 * Subject is willing to sign informed consent form

Exclusion criteria

* Active or severe IBD * Subjects with severe diverticulitis \\ diverticular disease (known or detected) * Known or detected colonic stenosis * Known or detected bowel obstruction * History of prior colon surgery * ASA≥IV (sever systemic disease) * Sever Renal insufficiency * Sever Liver insufficiency * Contraindication for colonoscopy anesthesia \\ sedation \\ prep agent pregnancy * Subjects with altered mental status/inability to provide informed consent * Subject has a condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound the study results, or may interfere significantly

Design outcomes

Primary

MeasureTime frameDescription
The Count and Percentage of Subjects Had Adequate Bowel Preparation After the Use of Motus Cleansing StystemFollowing the colonoscopic procedure- Up to 24 hours.The number of subjects had adequate bowel preparation after the use of Motus Cleansing System (i.e., all colon segments have BBPS\>=2) . Each colon segment was graded by using the Boston Bowel Preparation Score index before ( at baseline) and after the cleansing of the bowel by using the Motus Cleansing System.

Participant flow

Recruitment details

The study was conducted in 3 phases: Phase 1 - enrolled 6 subjects using Rev 2.0 of the device Phase 2 - enrolled 21 subjects using Rev 2.5 of the device Phase 3 - enrolled 20 subjects using Rev 3.0 of the device

Pre-assignment details

Patients had to follow a specific bowel preparation in order to mimic poor bowel preparation: Arm 1: start clear liquid diet 24 hours prior to the procedure Arm 2: start clear liquid diet 24 hours prior to the procedure Arm 3: start clear liquid diet 18 hours prior to the procedure along with 4 tables of 5 mg Bisacodyl in split dose

Participants by arm

ArmCount
Motus CleanC System Rev 2.0
Motus CleanC System Rev 2.0
6
Motus Cleansing System Rev 2.5
Motus Cleansing System Rev 2.5
21
Motus Cleansing System Rev 3.0
Motus Cleansing System Rev 3.0
20
Total47

Baseline characteristics

CharacteristicMotus CleanC System Rev 2.0Motus Cleansing System Rev 2.5Motus Cleansing System Rev 3.0Total
Age, Continuous48 YEARS
STANDARD_DEVIATION 8.7
49.2 YEARS
STANDARD_DEVIATION 11.6
54.7 YEARS
STANDARD_DEVIATION 6.6
51.4 YEARS
STANDARD_DEVIATION 9.6
Sex: Female, Male
Female
3 Participants7 Participants8 Participants18 Participants
Sex: Female, Male
Male
3 Participants14 Participants12 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 210 / 20
other
Total, other adverse events
3 / 62 / 210 / 20
serious
Total, serious adverse events
1 / 60 / 210 / 20

Outcome results

Primary

The Count and Percentage of Subjects Had Adequate Bowel Preparation After the Use of Motus Cleansing Stystem

The number of subjects had adequate bowel preparation after the use of Motus Cleansing System (i.e., all colon segments have BBPS\>=2) . Each colon segment was graded by using the Boston Bowel Preparation Score index before ( at baseline) and after the cleansing of the bowel by using the Motus Cleansing System.

Time frame: Following the colonoscopic procedure- Up to 24 hours.

Population: subjects had adequate bowel preparation after the use of Motus Cleansing System (i.e., all colon segments have BBPS\>=2)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Motus CleanC SystemThe Count and Percentage of Subjects Had Adequate Bowel Preparation After the Use of Motus Cleansing Stystem6 Participants
Motus Cleansing System Rev 2.5The Count and Percentage of Subjects Had Adequate Bowel Preparation After the Use of Motus Cleansing Stystem20 Participants
Motus Cleansing System Rev 3.0The Count and Percentage of Subjects Had Adequate Bowel Preparation After the Use of Motus Cleansing Stystem20 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026